Coverage
-
September 18, 2012
Allergan Inc. and two Japanese pharmaceutical companies on Monday failed in their renewed efforts to target Apotex Inc. for infringement of a patent used in Allergan's pinkeye treatment Zymar after a Delaware federal judge said a re-examination of the patent couldn't breathe life into the previously resolved dispute.
1 other articles on this case.
View all »